Bio?Sourcing and Zerion Pharma A/S today announce that their joint project to develop an oral formulation of Trastuzumab, the pioneer monoclonal antibody used to treat breast cancer, has been awarded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback